259 related articles for article (PubMed ID: 33960711)
1. Competing-risks nomograms for predicting cause-specific mortality in parotid-gland carcinoma: A population-based analysis.
Xu F; Feng X; Zhao F; Huang Q; Han D; Li C; Zheng S; Lyu J
Cancer Med; 2021 Jun; 10(11):3756-3769. PubMed ID: 33960711
[TBL] [Abstract][Full Text] [Related]
2. Nomograms for Estimating Cause-Specific Death Rates of Patients With Inflammatory Breast Cancer: A Competing-Risks Analysis.
Xu F; Yang J; Han D; Huang Q; Li C; Zheng S; Wang H; Lyu J
Technol Cancer Res Treat; 2021; 20():15330338211016371. PubMed ID: 34013802
[TBL] [Abstract][Full Text] [Related]
3. Competing-Risk Nomograms for Predicting the Prognosis of Patients With Infiltrating Lobular Carcinoma of the Breast.
Xu F; Li C; Li X; Huang Q; Han D; Wang H; Zheng S; Lyu J
Clin Breast Cancer; 2021 Dec; 21(6):e704-e714. PubMed ID: 33846097
[TBL] [Abstract][Full Text] [Related]
4. Nomogram to Predict Cause-Specific Mortality in Patients With Surgically Resected Stage I Non-Small-Cell Lung Cancer: A Competing Risk Analysis.
Zhou H; Zhang Y; Qiu Z; Chen G; Hong S; Chen X; Zhang Z; Huang Y; Zhang L
Clin Lung Cancer; 2018 Mar; 19(2):e195-e203. PubMed ID: 29153966
[TBL] [Abstract][Full Text] [Related]
5. Nomogram to predict cause-specific mortality of patients with rectal adenocarcinoma undergoing surgery: a competing risk analysis.
Zhang X; Xu F; Bin Y; Liu T; Li Z; Guo D; Li Y; Huang Q; Lyu J; He S
BMC Gastroenterol; 2022 Feb; 22(1):57. PubMed ID: 35144545
[TBL] [Abstract][Full Text] [Related]
6. Competing-Risks Model for Predicting the Postoperative Prognosis of Patients with Papillary Thyroid Adenocarcinoma Based on The Surveillance, Epidemiology, and End Results (SEER) Database.
Bian F; Li C; Han D; Xu F; Lyu J
Med Sci Monit; 2020 Jul; 26():e924045. PubMed ID: 32710734
[TBL] [Abstract][Full Text] [Related]
7. A novel postoperative nomogram and risk classification system for individualized estimation of survival among patients with parotid gland carcinoma after surgery.
Zhu R; Gong Z; Dai Y; Shen W; Zhu H
J Cancer Res Clin Oncol; 2023 Nov; 149(16):15127-15141. PubMed ID: 37633867
[TBL] [Abstract][Full Text] [Related]
8. Nomograms for Differentiated Thyroid Carcinoma Patients Based on the Eighth AJCC Staging and Competing Risks Model.
Li C; Xu F; Huang Q; Han D; Zheng S; Wu W; Zhao F; Feng X; Lyu J
JNCI Cancer Spectr; 2021 Jun; 5(3):. PubMed ID: 34159295
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in patients with gallbladder adenocarcinoma identified using competing-risks analysis: A study of cases in the SEER database.
Han D; Yang J; Xu F; Huang Q; Bai L; Wei YL; Kaaya RE; Wang S; Lyu J
Medicine (Baltimore); 2020 Jul; 99(31):e21322. PubMed ID: 32756116
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a preoperative nomogram for predicting survival of patients with locally advanced prostate cancer after radical prostatectomy.
Zhou X; Ning Q; Jin K; Zhang T; Ma X
BMC Cancer; 2020 Feb; 20(1):97. PubMed ID: 32019501
[TBL] [Abstract][Full Text] [Related]
11. Prediction of death probability in adenocarcinoma of the transverse colon: competing-risk nomograms based on 21,469 patients.
Su H; Wang S; Xie S; Huang L; Pan Y; Lyu J
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10435-10452. PubMed ID: 37278827
[TBL] [Abstract][Full Text] [Related]
12. A competing-risks nomogram and recursive partitioning analysis for cause-specific mortality in patients with esophageal neuroendocrine carcinoma.
Zhang G; Wu B; Wang X; Li J
Dis Esophagus; 2019 Dec; 32(11):. PubMed ID: 30715226
[TBL] [Abstract][Full Text] [Related]
13. Melanoma-specific mortality and competing mortality in patients with non-metastatic malignant melanoma: a population-based analysis.
Shen W; Sakamoto N; Yang L
BMC Cancer; 2016 Jul; 16():413. PubMed ID: 27389173
[TBL] [Abstract][Full Text] [Related]
14. A Competing-Risks Nomogram in Patients with Metastatic Pancreatic Duct Adenocarcinoma.
Lu Y; Zhou Y; Cao Y; Shi Z; Meng Q
Med Sci Monit; 2019 May; 25():3683-3691. PubMed ID: 31102397
[TBL] [Abstract][Full Text] [Related]
15. Predicting cancer-specific mortality in patients with parotid gland carcinoma by competing risk nomogram.
Luo X; Liu S; Chen Y; Qiu X; Huang D; Zhang D; Liang Q; Yang Y; Zeng X
Head Neck; 2021 Dec; 43(12):3888-3898. PubMed ID: 34632674
[TBL] [Abstract][Full Text] [Related]
16. Competing-risk nomogram for predicting survival in patients with advanced (stage III/IV) gallbladder cancer: A SEER population-based study.
Wang J; Yang Y; Pan J; Qiu Y; Shen S; Wang W
Jpn J Clin Oncol; 2022 Apr; 52(4):353-361. PubMed ID: 35137118
[TBL] [Abstract][Full Text] [Related]
17. Model to Predict Cause-Specific Mortality in Patients with Head and Neck Adenoid Cystic Carcinoma: A Competing Risk Analysis.
Shen W; Sakamoto N; Yang L
Ann Surg Oncol; 2017 Aug; 24(8):2129-2136. PubMed ID: 28424937
[TBL] [Abstract][Full Text] [Related]
18. Competing-risks analysis for evaluating the prognosis of patients with microinvasive cutaneous squamous cell carcinoma based on the SEER database.
Zheng S; Xie S; Yu H; Duan X; He Y; Ho C; Wan Y; Hang T; Chen W; Lyu J; Deng L
BMC Med Res Methodol; 2023 Dec; 23(1):286. PubMed ID: 38062392
[TBL] [Abstract][Full Text] [Related]
19. A competing risk nomogram predicting cause-specific mortality in patients with lung adenosquamous carcinoma.
Wu X; Yu W; Petersen RH; Sheng H; Wang Y; Lv W; Hu J
BMC Cancer; 2020 May; 20(1):429. PubMed ID: 32416716
[TBL] [Abstract][Full Text] [Related]
20. A competing-risk nomogram to predict cause-specific death in elderly patients with colorectal cancer after surgery (especially for colon cancer).
Wang Z; Wang Y; Yang Y; Luo Y; Liu J; Xu Y; Liu X
World J Surg Oncol; 2020 Feb; 18(1):30. PubMed ID: 32019568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
